Reuters: J&J profit beats forecast, but drug sales dim

[chris]

J&J profit beats forecast, but drug sales dim
      

NEW YORK (Reuters) - Johnson & Johnson  on Tuesday said second-quarter earnings beat Wall Street's expectations as strong demand for its medical devices and consumer products overshadowed negligible growth of prescription drugs.
<p>You are not allowed to view links. Register or Login</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login